Immunocore Holdings IMCR
NASDAQ IMCR
$36.18 -1.39 (-3.70%)
As of: Sep 4, 2026 · 3:17 PM EDT

Immunocore Holdings (IMCR) Assets (QoQ) (2022 - 2026)

Analysis

Immunocore Holdings (IMCR) Assets (QoQ) (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn
5 Revolution Medicines 44.02 Bn 44.02 Bn -
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn
8 Royalty Pharma 28.43 Bn 27.59 Bn -
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
10 Immunocore Holdings 1.85 Bn 965.03 Mn 114.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.41%
Mar 31, 2026 0.45%
Dec 31, 2025 -3.20%
Sep 30, 2025 1.86%
Jun 30, 2025 5.29%
Mar 31, 2025 1.83%
Dec 31, 2024 -6.93%
Sep 30, 2024 5.99%
Jun 30, 2024 2.96%
Mar 31, 2024 66.50%
Dec 31, 2022 -2.53%